Compare AU
Compare DRUG vs. QHAL
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are DRUG and QHAL. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | QHAL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 62 |
Median incremental investment | $967.00 | $865.83 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $5,067.60 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | QHAL | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | QHAL.AX was created on 2019-03-21 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. QHAL.AX seeks to provide investors with access to a diversified portfolio of quality international companies from developed markets (ex-Australia) hedged into Australian dollars with the aim of providing investment returns, before fees and other costs, which track the performance of the Index. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | MSCI Global 'Quality' (ex-AUS hedged) (100 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (77.72 %) Switzerland (4.96 %) United Kingdom of Great Britain and Northern Ireland (4.17 %) |
Management fee | 0.57 % | 0.43 % |
Key Summary
DRUG | QHAL | |
|---|---|---|
Issuer | BetaShares | VanEck |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | MSCI World ex Australia Quality 100% Hedged to AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.43 % |
Price | $8.25 | $49.20 |
Size | $182.401 million | $1.531 billion |
10Y return | N/A | N/A |
Annual distribution/ dividend yield (5Y) | 1.90 % | 1.82 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 25/03/2019 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | QHAL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 62 |
Median incremental investment | $967.00 | $865.83 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $5,067.60 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | QHAL | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | QHAL |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |